JESSICA JEPSON: Open Payments
NPI 1184296550 · WORCESTER, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$967 in 36 payments from 11 companies in 2025. Trend: 2023 $217 · 2024 $923 · 2025 $967
Food & beverage: $967
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 10 | $290 |
| AstraZeneca Pharmaceuticals LP | 10 | $261 |
| GENZYME CORPORATION | 3 | $99 |
| BioCryst US Sales Co., LLC | 2 | $71 |
| GlaxoSmithKline, LLC. | 2 | $64 |
| ARS Pharmaceuticals Operations, Inc. | 2 | $55 |
| Grifols USA, LLC | 2 | $46 |
| Novartis Pharmaceuticals Corporation | 2 | $33 |
| Verona Pharma, Inc. | 1 | $23 |
| ABBVIE INC. | 1 | $21 |
Products named: DUPIXENT, TEZSPIRE, BREZTRI, ORLADEYO, NUCALA, NEFFY, Prolastin-C Liquid, Ohtuvayre.
Industry payments across MA — which companies pay providers there.
